| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
a Division of Research, Department of Obstetrics and Gynecology, Medical College of Ohio, Toledo, Ohio 43614
b New York Fertility Institute, New York, New York 10028
Development of a vaccine based on sperm antigens represents a promising approach to contraception. The sperm-zona pellucida (ZP) interaction constitutes the most important event in the fertilization process, and the molecular sequences involved at this site may provide the most attractive candidates for immunocontraception. In the present study, using the phase peptide display technique, a novel dodecamer sequence, designated as YLP12, was identified that is involved in sperm-ZP recognition/binding. The synthetic 12-mer peptide based on this sequence and its monovalent Fab' antibodies specifically and significantly (P < 0.05) inhibited human sperm-ZP binding. In Western blot and immunoprecipitation procedures, the YLP12 peptide recognized the ZP3 component of solubilized human ZP proteins. In the Western blot procedure involving 10 different human tissue extracts, the anti-YLP12 Fab' antibodies recognized a protein band of ~72 ± 2 kDa only in the testis lane. The peptide sequence was localized on the acrosomal region of the human sperm cell. These findings indicate that the novel testis-specific 12-mer YLP12 that is present in the acrosomal region and is involved in human sperm-ZP interaction may find applications in contraceptive vaccine development, as well as in diagnosis and treatment of male infertility mediated through sperm dysfunction.
1 Supported in part by NIH grant HD24425 to R.K.N. No funds from this grant were used for human IVF and for studies involving human oocyte zona pellucida.
2 Correspondence: Rajesh K. Naz, Division of Research, Health Education Building Rm. 211, Medical College of Ohio, 3055 Arlington Avenue, Toledo, OH 43614-5806. FAX: 419 383 4473; rnaz{at}mco.edu
This article has been cited by other articles:
|
|
 |
|
  A.S. Samuel and R.K. Naz Isolation of human single chain variable fragment antibodies against specific sperm antigens for immunocontraceptive development Hum. Reprod., June 1, 2008; 23(6): 1324 - 1337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Naz, S. K. Gupta, J. C. Gupta, H. K. Vyas, and a. G.P. Talwar Recent advances in contraceptive vaccine development: a mini-review Hum. Reprod., December 1, 2005; 20(12): 3271 - 3283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bohring and W. Krause Immune infertility: towards a better understanding of sperm (auto)-immunity: The value of proteomic analysis Hum. Reprod., May 1, 2003; 18(5): 915 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Naz and S. C. Chauhan Human Sperm-Specific Peptide Vaccine That Causes Long-Term Reversible Contraception Biol Reprod, August 1, 2002; 67(2): 674 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mettens and P. Monteyne Life-style vaccines Br. Med. Bull., July 1, 2002; 62(1): 175 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Kouba, M. W. Atkinson, A. R. Gandolf, and T. L. Roth Species-Specific Sperm-Egg Interaction Affects the Utility of a Heterologous Bovine In Vitro Fertilization System for Evaluating Antelope Sperm Biol Reprod, October 1, 2001; 65(4): 1246 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rattanachaiyanont, W. Weerachatyanukul, M.-C. Leveille, T. Taylor, D. D'Amours, D. Rivers, A. Leader, and N. Tanphaichitr Anti-SLIP1-reactive proteins exist on human spermatozoa and are involved in zona pellucida binding Mol. Hum. Reprod., July 1, 2001; 7(7): 633 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Naz and S. C. Chauhan Presence of antibodies to sperm YLP12 synthetic peptide in sera and seminal plasma of immunoinfertile men Mol. Hum. Reprod., January 1, 2001; 7(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
